44 results on '"Bosso, John V."'
Search Results
2. New and Emerging Biological Medications for Asthma, Allergic Rhinitis and Chronic Rhinosinusitis: a Concise Review
3. Long‐term aspirin desensitization has mucosal cytokine features of immune tolerance.
4. Eosinophilic granulomatosis with polyangiitis presenting as aspirin–exacerbated respiratory disease
5. Dupilumab‐related adverse events among patients with chronic rhinosinusitis with nasal polyposis.
6. Microbial metabolite succinate activates solitary chemosensory cells in the human sinonasal epithelium.
7. Readability and quality analysis of patient education materials in aspirin‐exacerbated respiratory disease.
8. The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease
9. What's New in the Diagnosis and Treatment of Aspirin-Exacerbated Respiratory Disease: A Brief Review.
10. Genetics of denatonium‐responsive bitter receptors in aspirin‐exacerbated respiratory disease.
11. Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease
12. Similarities between allergen sensitivity patterns of central compartment atopic disease and allergic rhinitis.
13. Steroid affected cytokines in aspirin‐exacerbated respiratory disease.
14. Utilizing Histopathology to Predict Success with Macrolide Therapy in CRS Patients.
15. Comparison of aspirin desensitization outcomes between men and women with AERD.
16. SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
17. Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey.
18. Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps.
19. A rare case of allergic sialadenitis successfully treated with dupilumab and sialendoscopy
20. Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis.
21. Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups.
22. Solitary chemosensory cells are innervated by trigeminal nerve endings and autoregulated by cholinergic receptors.
23. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of...
24. Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
25. Major complications of aspirin desensitization and maintenance therapy in aspirin‐exacerbated respiratory disease.
26. Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid use.
27. In vitro safety of ketotifen as a topical nasal rinse.
28. Chronic rhinosinusitis precipitated by tumor necrosis factor alpha inhibitors is the phenotype of chronic rhinosinusitis without nasal polyps.
29. Aural polyps in aspirin-exacerbated respiratory disease
30. Intranasal ketorolac-induced pancreatitis as a complication of modified oral aspirin desensitization in a patient with aspirin-exacerbated respiratory disease
31. Fungal extracts stimulate solitary chemosensory cell expansion in noninvasive fungal rhinosinusitis.
32. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
33. A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps
34. Preoperative Sinonasal Symptom Scores Predict Post-Surgery, Post-Aspirin Desensitization Disease Status in Aspirin Exacerbated Respiratory Disease
35. Alcohol‐induced respiratory symptoms improve after aspirin desensitization in patients with aspirin‐exacerbated respiratory disease.
36. Solitary chemosensory cells producing interleukin‐25 and group‐2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps.
37. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin‐exacerbated respiratory disease.
38. Editorial.
39. AERD: Quo Vadis?
40. Aspirin desensitization for aspirin‐exacerbated respiratory disease in the era of biologics: Clinical perspective.
41. Age as a factor in treatment of aspirin‐exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization.
42. Assessing adequacy of surgical extent in CRSwNP: The Completion of Surgery Index.
43. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
44. Pre-intervention SNOT-22 scores predict outcomes in aspirin exacerbated respiratory disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.